SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk
Clinical trial NCT03151343 · COMPLETED
Trial details
- NCT number
- NCT03151343
- Sponsor
- Caroline M Kistorp
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-29
- Primary completion
- 2020-05-22
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.